Quadcap Wealth Management
TNYA icon

Quadcap Wealth Management’s Tenaya Therapeutics TNYA Stock Holding History

Quadcap Wealth Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.04K Hold
10,000
– – ﹤0.01% 433
2026
Q2 		$7.39K Hold
10,000
– – ﹤0.01% 430
2026
Q1 		$6.92K Hold
10,000
– – ﹤0.01% 398
2025
Q4 		$7.12K Buy
+10,000
New +$13.6K ﹤0.01% 394

Other funds holding TNYA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return
Mirador Capital Partners
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Almanack Investment Partners
Almanack Investment Partners Wayne, Pennsylvania $833M AUM 25.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
RS
R Squared Central, Hong Kong $188M AUM 18.2% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Quadcap Wealth Management's TNYA Position: Q3 2026 in Review

Quadcap Wealth Management held its Tenaya Therapeutics (TNYA) position steady in Q3 2026 at 10,000 shares worth $6.04K. The position accounts for ﹤0.01% of the portfolio, ranked #433.

Quadcap Wealth Management first reported a position in TNYA in Q4 2025 and has held it in 4 quarters since. The position peaked at $7.39K in Q2 2026. 33 funds tracked by Wall St. Rank hold TNYA as of Q3 2026.

  • Quadcap Wealth Management held 10,000 shares of Tenaya Therapeutics worth $6.04K as of Q3 2026.
  • Quadcap Wealth Management left its Tenaya Therapeutics share count unchanged in Q3 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Quadcap Wealth Management's portfolio in Q3 2026, its #433 holding.
  • Quadcap Wealth Management first reported a position in Tenaya Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Quadcap Wealth Management's Tenaya Therapeutics position peaked at $7.39K in Q2 2026.
  • 33 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2026.

Based on Quadcap Wealth Management's 13F filing for Q3 2026, filed 2 Nov 2026.